Gossamer Bio Inc reports results for the quarter ended in June - Earnings Summary

Gossamer Bio

08/08/2023 22:00

* Gossamer Bio Inc  GOSS.OQ  reported a quarterly adjusted
loss
of 45 cents​​ per share for the quarter ended in June. The mean
expectation of ten analysts for the quarter was for a loss of 49
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Gossamer Bio Inc's reported EPS for the quarter was a loss
of 45
cents​.
    * The mean earnings estimate of analysts had risen by
about 2.5%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Gossamer Bio Inc shares had risen by 7.5% this quarter and
lost 40.6% so far this year.
    * The company reported a quarterly loss of $42.5 million.
    * Wall Street's median 12-month price target for Gossamer
Bio Inc
is $4.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 09:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.49          -0.45          Beat
 Mar. 31 2023      -0.53          -0.52          Beat
 Dec. 31 2022      -0.62          -0.59          Beat
 Sep. 30 2022      -0.64          -0.65          Missed